News & Updates
Filter by Specialty:
High selenium concentrations may reduce death risk in diabetics
Greater concentrations of selenium appear to lower all-cause and heart disease mortality among individuals with type 2 diabetes (T2D), suggests a study.
High selenium concentrations may reduce death risk in diabetics
15 Jan 2022
Acute HF patients with diabetes derive less frailty benefit from physical rehab
Older diabetic patients with acute heart failure who undergo physical rehabilitation have worse baseline physical function but demonstrate similar clinically meaningful improvements from the intervention, results of the Rehabilitation Therapy in Older Acute Heart Failure Patients (REHAB-HF) trial have shown. However, the benefit derived for frailty is lesser among those with diabetes.
Acute HF patients with diabetes derive less frailty benefit from physical rehab
15 Jan 2022
Cardiac rehabilitation improves short-term outcomes in HF patients
Cardiac rehabilitation is standard for the treatment of heart failure (HF) and yields short-term prognostic benefits, a recent study has found. However, long-term benefits remain uncertain.
Cardiac rehabilitation improves short-term outcomes in HF patients
15 Jan 2022
Why does bariatric surgery confer better cardiovascular benefit to diabetics?
Differential changes in fasting serum levels of fibroblast growth factor (FGF)-19 and FGF-21 may help account for the superior cardiovascular benefit of bariatric surgery on obese patients with type 2 diabetes mellitus vs nondiabetics, a recent study has found.
Why does bariatric surgery confer better cardiovascular benefit to diabetics?
14 Jan 2022
Do antihypertensive drugs raise odds of COVID-19 diagnosis, death?
Antihypertensive therapy (AHT) may be used safely during the COVID-19 pandemic, as no evidence suggest that it can increase the risk of SARS-CoV-2 infection or death, according to a UK study. In addition, most classes of antihypertensives are negatively associated with COVID-19 diagnosis.